SWG Grant-funded projects, 2025
In November and December 2024, SWGs were invited to develop project ideas and apply for a 2025 SWG Grant.
For the 2025 call, EHA offered five grants, each worth €30,000. This was an increase on the previous funding level, which was three grants of €20,000 each. The EHA Board made this change in recognition of the increased interest in the grant from SWG members.
Applications
We received 15 different applications from nine SWGs. This was four more applications than we received in 2023 and six more than in 2022.
These applications came from the:
- SWG on Immune Therapies for Hematologic Disorders (2 applications)
- SWG on Myelodysplastic Syndromes (MDS) (1 application)
- SWG on Infections in Hematology (1 application)
- SWG on Granulocytes and Constitutional Marrow Failure Disorders (2 applications)
- EHA Lymphoma Group (2 applications)
- SWG on Red Cells and Iron (2 applications)
- SWG on Pediatric Hematology (2 applications)
- SWG on Genetic predisposition to blood cancers (rare diseases) (1 application)
- SWG on Aging in Hematology (2 applications)
Winners
All applications were reviewed against our selection criteria by SWG Committee members. These criteria are explained on the main SWG Grants page.
After careful consideration and fruitful discussion, the SWG Committee chose the following winners:
- Epidemiology of infection in AML: A European Hematology Association survey (EPIAMLINF) (SWG on Infections in Hematology)
- Gaucher disease (GD) non-interventional clinical audit study (SWG on Granulocytes and Constitutional Marrow Failure Disorders)
- Unraveling the biological landscape of Hodgkin lymphoma in older patients (joint application from SWG on Aging in Hematology and EHA Lymphoma group)
- Secondary leukemogenesis in the context of T-cell based immunotherapies (SWG on Immune Therapies for Hematologic Disorders)
- CRYSTAL-Immune pump-priming (SWG on Pediatric Hematology)